Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIII

Are condylar head and neck inclinations associated with condylar volume changes following maxillomandibular advancement surgery?

International journal of oral and maxillofacial surgery·2026

Three-dimensional assessment of temporomandibular joint changes following maxillomandibular advancement surgery: a five-year follow-up study.

International journal of oral and maxillofacial surgery·2024

Virtual surgical analysis: long-term cone beam computed tomography stability assessment of segmental bimaxillary surgery.

International journal of oral and maxillofacial surgery·2022

Autotransplantation of premolars: does surgeon experience matter?

International journal of oral and maxillofacial surgery·2018

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Use of recombinant factor VIIa in surgery in factor-VII-deficient patients.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Scrub typhus triggers hemophagocytic lymphohistiocytosis in children: metagenomic next-generation sequencing enables rapid diagnosis.

Frontiers in public health·2026

homeRNA Just Dropped! Streamlining Remote Blood Collection and RNA Stabilization for Smaller Sample Volumes with homeRNAdrop.

bioRxiv : the preprint server for biology·2026

Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda.

Wellcome open research·2026

Red blood cell transfusion in sickle cell disease: From clinical necessity to immunological complexity.

Transfusion medicine (Oxford, England)·2026

Macrophage-Derived, Rather Than Microglial, Cathepsin B Exacerbates Brain Injury After Ischemic Stroke.

Glia·2026

CD25-based graft-versus-host disease prophylaxis after haploidentical hematopoietic stem cell transplantation: comparison of two prophylactic strategies.

Haematologica·2026

Related Experiment Videos

Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIII

Related Concept Videos

Are condylar head and neck inclinations associated with condylar volume changes following maxillomandibular advancement surgery?

Three-dimensional assessment of temporomandibular joint changes following maxillomandibular advancement surgery: a five-year follow-up study.

Virtual surgical analysis: long-term cone beam computed tomography stability assessment of segmental bimaxillary surgery.

Autotransplantation of premolars: does surgeon experience matter?

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.

Use of recombinant factor VIIa in surgery in factor-VII-deficient patients.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Scrub typhus triggers hemophagocytic lymphohistiocytosis in children: metagenomic next-generation sequencing enables rapid diagnosis.

homeRNA Just Dropped! Streamlining Remote Blood Collection and RNA Stabilization for Smaller Sample Volumes with homeRNAdrop.

Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda.

Red blood cell transfusion in sickle cell disease: From clinical necessity to immunological complexity.

Macrophage-Derived, Rather Than Microglial, Cathepsin B Exacerbates Brain Injury After Ischemic Stroke.

CD25-based graft-versus-host disease prophylaxis after haploidentical hematopoietic stem cell transplantation: comparison of two prophylactic strategies.

Related Experiment Videos

Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIII

Related Concept Videos

Related Articles